Reacción #2886

ord-2c61f63832514f10a9e3abea4cbd484d

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    workup.STIRRINGThe resulting suspension is stirred for 15 minutes at -40° C. and for 3 hours at room temperature
  2. 2
    Otrothe tetrahydrofuran is evaporated
  3. 3
    ExtracciónThe resulting aqueous phase is extracted with chloroform
  4. 4
    LavadoThe chloroform phase is washed with water
  5. 5
    Secadodried with anhydrous sodium sulfate
  6. 6
    Otroevaporated to dryness
  7. 7
    Otroa crude product being obtained which
  8. 8
    Otrois purified by chromatography on silica gel

Procedimiento

A solution of 1.0 g (3.3 mmol) of 4,5-dichloro-2-methyl-1-[4-(4-oxo-1-piperidyl)butyl]-1H-imidazole in 10 ml of anhydrous tetrahydrofuran is added to a suspension of 1.08 g (11.4 mmol) of MgCl2 in 15 ml of anhydrous THF at -40° C. and under a nitrogen atmosphere. The mixture is stirred for 5 minutes and then, at -40° C., 6.8 ml of a 1.0M solution of 4-methylphenylmagnesium bromide are added. The resulting suspension is stirred for 15 minutes at -40° C. and for 3 hours at room temperature. An aqueous ammonium chloride solution is then added and the tetrahydrofuran is evaporated. The resulting aqueous phase is extracted with chloroform. The chloroform phase is washed with water, dried with anhydrous sodium sulfate and evaporated to dryness, a crude product being obtained which is purified by chromatography on silica gel, giving 1.02 g (2.6 mmol) of 4,5-dichloro-1-{4-[4-hydroxy-4-(4-methylphenyl)-1-piperidyl]butyl}-2-methyl-1H-imidazole.

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US05731331uspto-grants-1998_03